Sydney Ferrell, | |
18551 E 160th Ave, Brighton, CO 80601-8519 | |
(518) 256-5927 | |
Not Available |
Full Name | Sydney Ferrell |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 18551 E 160th Ave, Brighton, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013320795 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sydney Ferrell, 705 Parthenon Ct, Lafayette, CO 80026-8802 Ph: () - | Sydney Ferrell, 18551 E 160th Ave, Brighton, CO 80601-8519 Ph: (518) 256-5927 |
News Archive
Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.
With the G20 summit opening today in Toronto, World Vision is calling upon emerging economies within the G20 to be accountable for prioritizing their own child and maternal health progress - and for all G20 nations to provide their fair share of funding and leadership within their respective regions.
In the largest known brain imaging study, scientists from Amen Clinics, Google, John's Hopkins University, University of California, Los Angeles and the University of California, San Francisco evaluated 62,454 brain SPECT scans of more than 30,000 individuals from 9 months old to 105 years of age to investigate factors that accelerate brain aging. SPECT tomography evaluates regional cerebral blood flow in the brain that is reduced in various disorders.
The dermatology community is inadequately prepared for a biological disaster and would benefit from a formal preparedness training program, according to a study from the George Washington University.
Pfizer has announced that it has acquired the sanofi-aventis worldwide rights to Exubera (inhaled human insulin). Pfizer received approval last month to market Exubera in the United States and the European Union for the treatment of adults with type 1 and type 2 diabetes.
› Verified 3 days ago
Essence Of Communication, Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 N 1st Ave Ste 190, Brighton, CO 80601 Phone: 303-659-4090 | |
Ms. Rebecca Brown Rumsey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Platte River Blvd Unit O, Brighton, CO 80601 Phone: 303-659-8822 | |
Malorie Young, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18551 E 160th Ave, Brighton, CO 80601 Phone: 303-655-2900 | |
Kathleen Grace Collins Carrasco, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18551 E 160th Ave, Brighton, CO 80601 Phone: 720-299-3318 | |
Carol I Chadwick, M.S.,C.C.C. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1606 Prairie Center Pkwy Ste 120, Brighton, CO 80601 Phone: 303-659-4090 Fax: 720-685-9114 | |
Ms. Cassie Lynn Pavlovic, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Platte River Blvd, Unit O, Brighton, CO 80601 Phone: 303-659-8822 |